DXtrade says Bappebti approval opens an Indonesian route for its broker platform

DXtrade says Indonesia’s commodity-futures regulator, Bappebti, has approved its broker-platform software for licensing by supervised commodity-futures and derivatives brokers. The company disclosed the approval on 22 September; the regulator’s public checker confirms Bappebti’s role but does not independently list this platform-specific event.

The trading-platform product developed by Devexperts says the approval was issued in August. The issuer says it opens a route for Bappebti-supervised brokers to seek authorisation to license the platform; it does not identify a broker customer, launch date or transaction volume.

Bappebti’s public legal-entity checker describes the agency as part of Indonesia’s Ministry of Trade and provides its participant lists. It did not provide a searchable event-specific record for DXtrade in this review, so the approval details remain an issuer disclosure.

Devexperts says DXtrade is one of only two trading platforms approved by Bappebti. That exclusivity claim remains attributed to Devexperts because the company’s announcement does not name the other platform or link to an underlying Bappebti decision.

For Indonesian brokers, the practical signal is a potential technology option that has gone through the regulator’s stated review process. It does not establish a broker implementation, customer availability, revenue, market share or approval by another regulator.

What to watch: a named broker implementation, a Bappebti decision or register entry identifying DXtrade, or a separate approval from another Indonesian authority. None is established by the 22 September release.

Image note: Illustrative scene created for Southeast Asia Connect.

Source note: Original DXtrade release, 22 September 2026.